TGRX-326 Chinese Phase I for Advanced Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT05441956 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05441956
- Sponsor
- Shenzhen TargetRx Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-23
- Primary completion
- 2025-08-31
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.